SCHEMBL7729577

SCHEMBL7729577

COC(=O)[C@H]1C[C@H](NC(=O)OC(C)(C)C)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.48
BTK Q06187 1/20 0.48
HSD11B1 P28845 9/20 0.46
CYP2C9 P11712 1/20 0.46
EPHX1 P07099 1/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SCN4A P35499 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726769 1.00 CTSK (0.48) CTSKBTKHSD11B1CYP2C9EPHX1
SCHEMBL7727313 0.88 BTK (0.46) CTSKBTKHSD11B1CYP2C9CA1
SCHEMBL7731684 0.88 BTK (0.46) CTSKBTKHSD11B1CYP2C9CA1
SCHEMBL7727315 0.88 BTK (0.46) CTSKBTKHSD11B1CYP2C9CA1
SCHEMBL7728646 0.88 BTK (0.56) CTSKBTKHSD11B1CYP2C9EPHX1
SCHEMBL7728383 0.88 BTK (0.56) CTSKBTKHSD11B1CYP2C9EPHX1
SCHEMBL443655 0.82 HSD17B10 (0.47) EPHX1NR1H2NR1H3HSD17B10SCN4A
SCHEMBL26353928 0.82 HSD17B10 (0.47) EPHX1NR1H2NR1H3HSD17B10SCN4A
SCHEMBL2995875 0.82 HSD17B10 (0.47) EPHX1NR1H2NR1H3HSD17B10SCN4A
SCHEMBL1975610 0.82 CHRM2 (0.45) NR1H2NR1H3HSD17B10KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed